23-044-155
Quidel Sofia 2 Flu+SARS Antigen FIA (25T)
Manufacturer: Quidel
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Pack of 25 | 23-044-155-Pack-of-25 | In Stock | ₹ 61,774.32 |
23-044-155 - Pack of 25
In Stock
Quantity
1
Base Price: ₹ 61,774.32
GST (18%): ₹ 11,119.378
Total Price: ₹ 72,893.698
Certifications/Compliance
End-User Placement Agreement Required
Control Sets
Included and available for purchase
Clia Complexity
Waived (EUA)
Sample Type
Direct: Nasal Swab, Nasopharyngael Swab
Type
Rapid Test
Packaging Type
12 Kits/Cs.
Specificity
Influenza A: NS - 95%, NPS - 94.6%Influenza B: NS - 96%, NPS - 97%SARS-CoV-2: 100%
Form
Liquid
Content And Storage
15°C to 35°C
CE Marker
No
Detectable Analytes
Influenza A and B, COVID-19/2019-nCOV
Sensitivity
Influenza A: NS - 90%, NPS - 97.1%Influenza B: NS - 89%, NPS - 90%SARS-CoV-2: 95.2%
For Use With (Application)
Instrument Read - advanced immunofluorescence-based lateral flow
Quantity
25
Test Time
15 min.
Related Products
Description
- Description One Sample - Three Results Results in 15 minutes Dual Work Modes Virena Connection All necessary components included in kit Self-contained Test cassette For use with Sofia 2 FDA Emergency Use Authorization.
SAFETY INFORMATION
- ShelfLife : 12 Months from DOM
Compare Similar Items
Show Difference
Certifications/Compliance: End-User Placement Agreement Required
Control Sets: Included and available for purchase
Clia Complexity: Waived (EUA)
Sample Type: Direct: Nasal Swab, Nasopharyngael Swab
Type: Rapid Test
Packaging Type: 12 Kits/Cs.
Specificity: Influenza A: NS - 95%, NPS - 94.6%Influenza B: NS - 96%, NPS - 97%SARS-CoV-2: 100%
Form: Liquid
Content And Storage: 15°C to 35°C
CE Marker: No
Detectable Analytes: Influenza A and B, COVID-19/2019-nCOV
Sensitivity: Influenza A: NS - 90%, NPS - 97.1%Influenza B: NS - 89%, NPS - 90%SARS-CoV-2: 95.2%
For Use With (Application): Instrument Read - advanced immunofluorescence-based lateral flow
Quantity: 25
Test Time: 15 min.
Certifications/Compliance:
End-User Placement Agreement Required
Control Sets:
Included and available for purchase
Clia Complexity:
Waived (EUA)
Sample Type:
Direct: Nasal Swab, Nasopharyngael Swab
Type:
Rapid Test
Packaging Type:
12 Kits/Cs.
Specificity:
Influenza A: NS - 95%, NPS - 94.6%Influenza B: NS - 96%, NPS - 97%SARS-CoV-2: 100%
Form:
Liquid
Content And Storage:
15°C to 35°C
CE Marker:
No
Detectable Analytes:
Influenza A and B, COVID-19/2019-nCOV
Sensitivity:
Influenza A: NS - 90%, NPS - 97.1%Influenza B: NS - 89%, NPS - 90%SARS-CoV-2: 95.2%
For Use With (Application):
Instrument Read - advanced immunofluorescence-based lateral flow
Quantity:
25
Test Time:
15 min.
Certifications/Compliance: End-User Placement Agreement Required
Control Sets: Included and available for purchase
Clia Complexity: Waived (EUA)
Sample Type: Direct: Nasal Swab, Nasopharyngael Swab
Type: Rapid Test
Packaging Type: 1 Each (Analyzer, Test Kit)
Specificity: Influenza A: NS - 95%, NPS - 94.6%Influenza B: NS - 96%, NPS - 97%SARS-CoV-2: 100%
Form: Liquid
Content And Storage: 15°C to 35°C
CE Marker: __
Detectable Analytes: Influenza A and B, COVID-19/2019-nCOV
Sensitivity: Influenza A: NS - 90%, NPS - 97.1%Influenza B: NS - 89%, NPS - 90%SARS-CoV-2: 95.2%
For Use With (Application): Instrument Read - advanced immunofluorescence-based lateral flow
Quantity: 1
Test Time: 15 min.
Certifications/Compliance:
End-User Placement Agreement Required
Control Sets:
Included and available for purchase
Clia Complexity:
Waived (EUA)
Sample Type:
Direct: Nasal Swab, Nasopharyngael Swab
Type:
Rapid Test
Packaging Type:
1 Each (Analyzer, Test Kit)
Specificity:
Influenza A: NS - 95%, NPS - 94.6%Influenza B: NS - 96%, NPS - 97%SARS-CoV-2: 100%
Form:
Liquid
Content And Storage:
15°C to 35°C
CE Marker:
__
Detectable Analytes:
Influenza A and B, COVID-19/2019-nCOV
Sensitivity:
Influenza A: NS - 90%, NPS - 97.1%Influenza B: NS - 89%, NPS - 90%SARS-CoV-2: 95.2%
For Use With (Application):
Instrument Read - advanced immunofluorescence-based lateral flow
Quantity:
1
Test Time:
15 min.
Certifications/Compliance: Emergency Use Authorization (EUA)
Control Sets: __
Clia Complexity: __
Sample Type: __
Type: Nasopharyngeal
Packaging Type: __
Specificity: __
Form: __
Content And Storage: __
CE Marker: __
Detectable Analytes: __
Sensitivity: __
For Use With (Application): Solana Instrument
Quantity: 96/Kit
Test Time: __
Certifications/Compliance:
Emergency Use Authorization (EUA)
Control Sets:
__
Clia Complexity:
__
Sample Type:
__
Type:
Nasopharyngeal
Packaging Type:
__
Specificity:
__
Form:
__
Content And Storage:
__
CE Marker:
__
Detectable Analytes:
__
Sensitivity:
__
For Use With (Application):
Solana Instrument
Quantity:
96/Kit
Test Time:
__
Certifications/Compliance: __
Control Sets: __
Clia Complexity: __
Sample Type: __
Type: Quality Control
Packaging Type: __
Specificity: __
Form: __
Content And Storage: __
CE Marker: __
Detectable Analytes: SARS-CoV-2
Sensitivity: __
For Use With (Application): __
Quantity: 1 Tube/Kit
Test Time: __
Certifications/Compliance:
__
Control Sets:
__
Clia Complexity:
__
Sample Type:
__
Type:
Quality Control
Packaging Type:
__
Specificity:
__
Form:
__
Content And Storage:
__
CE Marker:
__
Detectable Analytes:
SARS-CoV-2
Sensitivity:
__
For Use With (Application):
__
Quantity:
1 Tube/Kit
Test Time:
__